US Patent 7176303 Modulation of STAT5 expression

Patent 7176303 was granted and assigned to Ionis Pharmaceuticals on February, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 27 Jun, 2024

"update inverses"

Golden AI

edited on 27 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12016314 MicroRNA inhibitor therapy in systemic lupus erythematosus

Edits on 7 Dec, 2023

"update inverses"

Golden AI

edited on 7 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11834661 Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Edits on 6 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 6 Sep, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

James Karras0

Susan M. Freier0

Edits on 31 Aug, 2023

"Add patent abstract"

Golden AI

edited on 31 Aug, 2023

Edits made to:

Article (+365 characters)

Article

Patent abstract

Compounds, compositions and methods are provided for modulating the expression of STAT5. The compositions comprise oligonucleotides, targeted to nucleic acid encoding STAT5. Methods of using these compounds for modulation of STAT5 expression and for diagnosis and treatment of diseases and conditions associated with expression of STAT5 are provided.

Edits on 25 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 25 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=071763030

Edits on 21 May, 2023

"Remove leading 0 from patent number"

Golden AI